AKT1 and nervous system disorder: In the present study, mouse ICH model was used to provide proof-of-principle that hNSCs genetically modified to express Akt1, a general mediator of cell survival signals, can be transplanted in the brain of animal models of neurological diseases, and produces beneficial effects of increased survival of grafted NSCs and consequent functional recovery.